Sign Up to like & get
recommendations!
1
Published in 2022 at "European Journal of Immunology"
DOI: 10.1002/eji.202250022
Abstract: Abstract Replication‐incompetent adenovirus (Ad) vector and mRNA‐lipid nanoparticle (LNP) constructs represent two modular vaccine platforms that have attracted substantial interest over the past two decades. Due to the COVID‐19 pandemic and the rapid development of…
read more here.
Keywords:
vector mrna;
mrna vaccines;
adenovirus vector;